Celgene’s Hugin: We Should Charge a Fair Price

The transcript discusses the challenges and reforms needed in the pharmaceutical industry, focusing on drug pricing and value-based healthcare. Bob Hugin from Celgene talks about the need for system efficiency, regulatory changes, and the importance of innovation. The conversation also covers Celgene's growth strategy, emphasizing R&D and the potential of their drug pipeline. Additionally, the discussion touches on the evolution of the healthcare system and the impact of the Affordable Care Act.

What specific reforms are suggested to enhance the efficiency of the drug pricing system?

How does the aging population affect the demand for healthcare services?

What role does innovation play in addressing healthcare challenges such as Alzheimer's and cancer?